Rainbow Seed Fund News

Powered by Cytox’s genoSCORE, the new test enables physicians to support patients with lifestyle changes, and guide possible use of drug therapy, to delay the onset of disease symptoms 23 June 2021: Piscataway, New Jersey; Oxford and Manchester, UK. Today, Infinity BiologiX, LLC (IBX) and Cytox Ltd, announce a collaboration to provide a new, non-invasive, […]

read more

The UK Innovation and Science Seed Fund (UKI2S) is delighted to announce the collaboration of Atelerix and Perfectus Biomed Group, two of UKI2S’s portfolio companies. In May 2020, Atelerix announced that it had secured a government backed, Innovate UK grant to extend the shelf life of COVID-19 test kits. A severe limitation of swab samples is their short shelf life of […]

read more

30th March 2020, London: The UK Innovation and Science Seed Fund (UKI2S) has published an independent economic analysis showing how its investment and continuing support have generated benefits for early stage companies and for the UK economy as a whole. The report, by economic research specialists SQW Consulting, demonstrates the unique value of UKI2S in […]

read more

1 2 3 13